AI Maverick Intel to acquire HEAL Access, pivots to AI healthcare
What's the deal? AI Maverick Intel (OTC PINK:AIMV) has signed a definitive agreement to acquire 100% of HEAL Access CanadaDealroom has a profile for this one. Try Dealroom → from HEAL Group HoldingsDealroom has a profile for this one. Try Dealroom →, the company said on September 21. Terms were not disclosed, and the deal is subject to closing conditions.
What each side brings: AIMV is a Delaware corporation building operating businesses that apply artificial intelligence and data technologies to healthcare. HEAL AccessDealroom has a profile for this one. Try Dealroom → provides an operating platform for accessing, navigating, and delivering healthcare — the foundation AIMV plans to build its strategy around.
Why now? The acquisition is the first transaction under AIMV's right-of-first-refusal framework with HEAL Group. Alongside it, the company settled and mutually rescinded its August 2024 transaction with Stronghold Media GroupDealroom has a profile for this one. Try Dealroom →, reassigning the related intellectual property back to Stronghold.
The hire: AIMV appointed Dr. Wayne Young to its board, filling the seat previously held by Chelsea Reid. Young, a University of Alberta graduate in science and dental surgery, brings more than three decades of healthcare, clinical, and business experience.
"As AIMV develops its healthcare-focused AI strategy and works toward the acquisition and growth of HEAL Access, his perspective will be particularly relevant to the direction we are taking the Company," said chief executive officer Wayne Cockburn.
What's the endgame? AIMV intends to use HEAL Access as its initial platform while evaluating complementary opportunities in AI-enabled healthcare. It also plans a corporate name change, with a new identity to follow once regulatory processes are complete.
The signal: The deal marks a small-cap reset — a settlement to close out an old transaction paired with a fresh operating platform and sector-experienced leadership. It reflects the broader rush to attach AI to healthcare access and delivery, though execution and closing conditions remain the test.
Read more: pr-inside.com
Image credit: Generated with Gemini
